Australia markets open in 36 minutes

Factor Therapeutics Limited (FTT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00500.0000 (0.00%)
At close: 10:02AM AEST
Currency in AUD

Valuation measures

Market cap (intra-day) 55.21M
Enterprise value 3985.78k
Trailing P/E
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)7.75
Price/book (mrq)1.25
Enterprise value/revenue 31.47
Enterprise value/EBITDA 63.23

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3100.00%
S&P500 52-week change 326.32%
52-week high 30.0070
52-week low 30.0010
50-day moving average 30.0050
200-day moving average 30.0050

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.04B
Float 402.96M
% held by insiders 141.76%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 304 Feb 2009

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Dec 2020

Profitability

Profit margin 41.91%
Operating margin (ttm)44.86%

Management effectiveness

Return on assets (ttm)5.90%
Return on equity (ttm)9.31%

Income statement

Revenue (ttm)672.81k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)16.20%
Gross profit (ttm)860.22k
EBITDA 305.47k
Net income avi to common (ttm)281.99k
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.2M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)38.56
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)166.66k
Levered free cash flow (ttm)67.39k